The Defense Health Agency awarded a $2,377,839 Project Grant to The Regents of the University of California, San Francisco (UCSF) on June 1, 2025 under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the general public. Specifically, the funding will enable UCSF to conduct evidence-based prediction of cardiovascular risk in...
This federal Project Grant award of $1,041,595.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The Regents of the University of California, San Francisco, a prominent academic medical center and research institution, will conduct innovative scientific investigations spanning...
The Defense Health Agency awarded a $1,453,500.00 Project Grant to The Regents of the University of California, San Francisco (UCSF) under the Military Medical Research and Development program (CFDA 12.420). This 3-year grant, commencing on June 20, 2023, will support UCSF's research to profile and eliminate tumor subclones resistant to radioligand therapy. Through this project, UCSF aims to transform health care for Service Members and the American public by developing innovative and...
This federal Project Grant award of $442,750.00, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research at the University of California, Davis to determine the role of histone lactylation in post-traumatic osteoarthritis and arthritic pain. The project aims to advance understanding of the underlying mechanisms of these medical conditions, which are particularly relevant to military personnel and veterans. This 2-year...
The Regents of the University of California, San Francisco (UCSF) has been awarded a $499,985 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a 2-year research project titled "DIET, EXERCISE, AND INFLAMMATION IN EARLY-STAGE NEURONAL ALPHA-SYNUCLEIN DISEASE" to investigate novel approaches for treating neurodegenerative disorders relevant to military personnel and the broader population. As a...
This $1,008,313 federal Project Grant award was made by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Regents of the University of California, San Francisco (UCSF) on September 1, 2024. The grant will fund UCSF's Melanoma Research Program Team Science Award, which aims to advance innovative biomedical research to transform healthcare for military service members and the broader public. The grant will support a 3-year research program...
The Department of the Army Medical Command awarded a $161,500 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to The Regents of the University of California, San Francisco (UCSF) to conduct research on "Deciphering Translational Control of Androgen Receptor in Prostate Cancer". The grant project will run from April 1, 2024 to March 31, 2026. As a leading academic medical center and research institution, UCSF has extensive expertise in federal...
This $298,329 federal Project Grant awarded by the Defense Health Agency on March 1, 2024 under the Military Medical Research and Development program (CFDA 12.420) supports research by the University of Arkansas for Medical Sciences (UAMS) on the role of subchondral bone osteocytes in post-traumatic osteoarthritis. UAMS, a major academic medical center, will leverage its expertise in biomedical research to investigate this specific aspect of osteoarthritis development over the 2-year award...
The Defense Health Agency awarded a $2,528,000 Project Grant to the University of California, San Diego under the Military Medical Research and Development federal grant program (CFDA 12.420) to support research titled "MULTIPLEXED IN VIVO EPIGENOME ENGINEERING FOR THERAPEUTIC TARGETING OF CHRONIC PAIN." The four-year project beginning June 1, 2022 will investigate medical solutions for chronic pain through innovative epigenome engineering research with the goal of transforming...
This Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) provides $1,476,001.00 to the Regents of the University of California, San Francisco (UCSF) to investigate fundamental mechanisms of interorgan crosstalk in osteoarthritis. The research aims to determine how adipose tissue communicates with the knee joint through signaling pathways, cell migration, and nervous system mechanisms. The project...